A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults

Clinical trial NCT06890416 · COMPLETED

Trial details

NCT number: NCT06890416
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2025-04-04
Primary completion: 2025-09-30
Enrollment: 526

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.